The meta-analysis claims, "The level of protection against re-infection, symptomatic disease, and severe disease appears to be at least as durable, if not more so, than that provided by two-dose vaccination with the mRNA vaccines."
A new preprint by Wilson N. Sy, PhD, Director of the Biotechnology Unit at Investment Analytics Research located in Australia, finds that excess deaths in Australia in 2021 were likely due to vaccination, not COVID-19 mortality.
As the world continues to grapple with the ongoing COVID-19 pandemic, new questions have emerged about the origin of the virus and whether one of its more pathogenic variants, Delta, may have originated from Pfizer Inc.'s India operations.
A Pfizer executive claims in a video that the company had been exploring ways to "mutate" the coronavirus via "directed evolution" by experimenting on monkeys and the Delta variant, which is more contagious, was discovered in India a month after Pfizer announced its monkey research.
“Promise you won’t tell anyone. The way [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them," the Pfizer executive says.
The protection provided by a second COVID-19 vaccine booster was worse than that bestowed by an initial booster, with the shielding trending negative after a period of time, according to a new study.
